Ser1108

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Phosphorylation Site Page:

Ser1108 - eIF4G (rat)

Site Information

GGSGAKPsDTASEAT SwissProt Entrez-Gene

Predicted information: Scansite

Orthologous residues: eIF4G (mouse): S1110, eIF4G (rabbit): S909, eIF4G (human): S1106, eIF4G iso3 (human): S1066, eIF4G iso2 (mouse): S1096, eIF4G iso1 (human): S1107

Blast this site against: NCBI SwissProt PDB

In vivo Characterization

Methods used to characterize site in vivo:	phospho-antibody (1, 2), western blotting (1)
Relevant cell line - cell type - tissue:	'muscle, skeletal' (1, 2)

Controlled by

Treatments:

indinavir (2), insulin (2), leucine (1), sepsis (1)

	References

1	Vary TC (2007) Acute oral leucine administration stimulates protein synthesis during chronic sepsis through enhanced association of eukaryotic initiation factor 4G with eukaryotic initiation factor 4E in rats. J Nutr 137, 2074-9 17709445 Curated Info
2	Hong-Brown LQ, et al. (2005) Indinavir alters regulators of protein anabolism and catabolism in skeletal muscle. Am J Physiol Endocrinol Metab 289, E382-90 15827064 Curated Info

Home \| Curator Login	With enhanced literature mining using Linguamatics I2E		Produced by 3rd Millennium \| Design by Digizyme
			©2003-2013 Cell Signaling Technology, Inc.